Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Research|October 5, 2006
The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigensHailing Lu, Keith L Knutson, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2015
The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 DependentVy Phan-Lai, Yushe Dang, Ekram Gad, et al.
Molecular Carcinogenesis|September 9, 2015
Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancerJohnathan D Ebben, Ronald A Lubet, Ekram Gad, et al.
Vaccine|May 26, 2019
Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targetsSasha E Stanton, Ekram Gad, Lauren R Corulli, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2013
Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSKCarol Inatsuka, Yi Yang, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapyHailing Lu, Yi Yang, Ekram Gad, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2006
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic miceKeith L Knutson, Yushe Dang, Hailing Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cellsYushe Dang, Wolfgang M Wagner, Ekram Gad, et al.
Breast Cancer Research and Treatment|November 15, 2014
Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor modelsEkram Gad, Lauren Rastetter, Meredith Slota, et al.
Biomacromolecules|March 23, 2013
Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cellsVy Phan-Lai, Stephen J Florczyk, Forrest M Kievit, et al.
Pageof 3